These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 15826789)
21. The effect of anaesthetics on the myocardium--new insights into myocardial protection. Weber NC; Preckel B; Schlack W Eur J Anaesthesiol; 2005 Sep; 22(9):647-57. PubMed ID: 16163910 [TBL] [Abstract][Full Text] [Related]
22. Ischaemic preconditioning of the brain, mechanisms and applications. Steiger HJ; Hänggi D Acta Neurochir (Wien); 2007 Jan; 149(1):1-10. PubMed ID: 17151832 [TBL] [Abstract][Full Text] [Related]
23. Ischaemic preconditioning: from molecular characterisation to clinical application--part II. Riksen NP; Smits P; Rongen GA Neth J Med; 2004 Dec; 62(11):409-23. PubMed ID: 15685892 [TBL] [Abstract][Full Text] [Related]
24. Cardiac protection by volatile anaesthetics: a review. Landoni G; Fochi O; Torri G Curr Vasc Pharmacol; 2008 Apr; 6(2):108-11. PubMed ID: 18393912 [TBL] [Abstract][Full Text] [Related]
25. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart. Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926 [TBL] [Abstract][Full Text] [Related]
26. Ischaemic preconditioning: from molecular characterisation to clinical application--part I. Riksen NP; Smits P; Rongen GA Neth J Med; 2004 Nov; 62(10):353-63. PubMed ID: 15683090 [TBL] [Abstract][Full Text] [Related]
27. Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists. Kato R; Foëx P Can J Anaesth; 2002 Oct; 49(8):777-91. PubMed ID: 12374705 [TBL] [Abstract][Full Text] [Related]
28. The concept of anaesthetic-induced cardioprotection: mechanisms of action. Weber NC; Schlack W Best Pract Res Clin Anaesthesiol; 2005 Sep; 19(3):429-43. PubMed ID: 16013692 [TBL] [Abstract][Full Text] [Related]
29. Sevoflurane post-conditioning protects against myocardial reperfusion injury by activation of phosphatidylinositol-3-kinase signal transduction. Li H; Wang JK; Zeng YM; Yang CX; Chen HT; Wen XJ; Shui CL; Liang H Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1043-51. PubMed ID: 18505453 [TBL] [Abstract][Full Text] [Related]
30. Cardioprotection via activation of protein kinase C-delta depends on modulation of the reverse mode of the Na+/Ca2+ exchanger. Bouwman RA; Salic K; Padding FG; Eringa EC; van Beek-Harmsen BJ; Matsuda T; Baba A; Musters RJ; Paulus WJ; de Lange JJ; Boer C Circulation; 2006 Jul; 114(1 Suppl):I226-32. PubMed ID: 16820577 [TBL] [Abstract][Full Text] [Related]
31. Comparison of isoflurane-, sevoflurane-, and desflurane-induced pre- and postconditioning against myocardial infarction in mice in vivo. Redel A; Stumpner J; Tischer-Zeitz T; Lange M; Smul TM; Lotz C; Roewer N; Kehl F Exp Biol Med (Maywood); 2009 Oct; 234(10):1186-91. PubMed ID: 19596824 [TBL] [Abstract][Full Text] [Related]